No items found.
Empower Pharmacy is one of the largest compounding pharmacies in the United States, operating both 503A and 503B facilities from their Houston, Texas headquarters. They supply compounded GLP-1 medications to numerous telehealth platforms and clinics nationwide. It is important to understand that Empower is a pharmacy supplier, not a direct-to-consumer telehealth service. You cannot order from them directly - you access their products through a prescribing provider. With a Trustpilot rating of 2.0 out of 5, their consumer reviews reflect significant concerns.
Empower operates one of the largest compounding facilities in North America, giving them significant production capacity across both 503A (individual prescriptions) and 503B (bulk outsourcing) operations. They hold PCAB accreditation and NABP verification, and offer a broad product catalog beyond GLP-1 medications, including hormone therapy, peptides, NAD+ injections, sexual health, mental health, dermatology, and nutritional injectables. Their scale means many popular telehealth platforms partner with them, making their products widely available. They offer a 25% uniformed services discount for military and first responders. Nationwide shipping is available including Puerto Rico, with both ground and overnight options.
The concerns around Empower are substantial. FDA 483 inspection findings from May 2024 documented fill weight discrepancies in semaglutide vials, inadequate quality control sampling procedures, and deficiencies in their aseptic processing areas. An ongoing Eli Lilly lawsuit over tirzepatide compounding adds legal uncertainty. Consumer reviews frequently cite medication effectiveness issues, shipping problems including products arriving warm without ice packs, poor communication, and billing disputes. The 1.9-star Trustpilot rating with 58% 1-star reviews is among the lowest in the compounding pharmacy space.
Empower Pharmacy is a major player in the compounding industry with significant scale, but their quality control findings and poor consumer reviews raise legitimate concerns. If your telehealth provider uses Empower as their pharmacy, it is worth asking about quality assurance measures and considering whether alternative pharmacy partners are available. The FDA inspection findings and ongoing legal challenges should factor into your decision-making.
No. Empower Pharmacy is a compounding pharmacy, not a telehealth provider. They manufacture and supply compounded medications to healthcare providers, clinics, and other pharmacies. Patients cannot order directly from Empower, they need a prescription from a licensed provider who works with Empower. Empower supplies medications to several telehealth platforms including Mochi Health and Lavender Sky Health.
Empower Pharmacy compounds semaglutide with cyanocobalamin (vitamin B12) injection and tirzepatide with niacinamide (vitamin B3) injection. They also offer a tirzepatide ODT (orally dissolving tablet), which is the subject of the Eli Lilly lawsuits. These are compounded versions, not brand-name FDA-approved medications, and they are not FDA-approved for safety, efficacy, or quality.
Empower has received FDA warning letters in 2017, 2021, and April 2025, plus Form 483 observations in 2020 and 2024. The April 2025 warning letter cited insanitary conditions in sterile drug preparation, failure to respond to microbial contamination, inadequate labeling, and deficient corrective actions. The FDA stated that management oversight of drug manufacturing was "inadequate." Empower also recalled Pyridoxine HCL Injection after contamination was found during inspection. At least a dozen states have brought enforcement actions against Empower in the last decade.
Yes. Eli Lilly filed two separate lawsuits against Empower — one in April 2025 in New Jersey and another in July 2025 in Texas — alleging unlawful manufacturing and misleading marketing of tirzepatide products. Lilly also sent cease and desist letters to approximately 50 additional compounders. Additionally, a former Empower employee has made serious whistleblower allegations about quality and compliance practices in court filings, including alleged use of non-pharmaceutical grade ingredients. These are allegations in litigation and have not been proven in court.
Patients access Empower Pharmacy's compounded medications through their healthcare provider. A licensed clinician must write a prescription, which Empower then fills and ships. Many telehealth platforms and weight loss clinics use Empower as one of their pharmacy partners for compounded GLP-1 medications. Patients should ask their telehealth provider which pharmacy compounds their medication.
